Symptom Interactions in Cancer and Immune Disorders (R21) | Apply Online

Opportunity Summary:

The Symptom Interactions in Cancer and Immune Disorders (R21) opportunity (Funding Opportunity Number PA-08-122) is an NIH discretionary grant announcement led by the National Institute of Nursing Research (NINR) with participation from the National Cancer Institute (NCI) and the National Institute on Aging (NIA). Its core goal is to move symptom science beyond simply noting that multiple symptoms happen at the same time and instead focus on how symptoms relate to and influence one another in cancer and immune-related disorders, including across treatment and survivorship. The emphasis is on biobehavioral symptom interactions, meaning applicants are expected to consider both biological and behavioral factors that may connect symptoms, shape their trajectories, or explain why certain symptoms tend to occur together and worsen outcomes.

The FOA invites projects that do one or more of the following: first, identify and measure interactions among two or more related, co-occurring symptoms; second, characterize the mechanisms and pathways that underlie those interactions (for example, physiologic, inflammatory, neuroendocrine, behavioral, or psychosocial pathways); third, clarify what level or pattern of interaction is strong enough to justify labeling a set of symptoms as a true "symptom cluster" rather than just co-occurrence; and fourth, design and test interventions that directly target interacting or clustered symptoms, with the expectation that addressing the interaction (not just each symptom in isolation) could improve patient outcomes. A key requirement is that applicants provide a clear rationale for why the selected symptoms belong together conceptually or mechanistically; it is not sufficient to pick symptoms just because they are commonly reported at the same time. The symptoms studied must also be meaningfully tied to a specific disease or syndrome, or to the treatment of that condition.

The mechanism is the NIH R21, which is generally intended for exploratory or early-stage research that can generate preliminary data, test novel concepts, or develop innovative approaches that may later support larger, more definitive studies. This R21 announcement runs in parallel with a companion FOA of the same scientific scope using the R01 mechanism (PA-08-121), which is typically better suited for more mature projects with stronger preliminary evidence and broader aims. The R21 under this FOA has an award ceiling of $200,000, and awards depend on available funds as well as the number and quality of applications received. The solicitation also explicitly encourages research at any point along the disease trajectory, including active disease, treatment phases, and survivorship, which signals interest in how symptom interactions evolve over time and across clinical contexts.

Eligibility is broad and includes many types of applicant organizations. Eligible applicants include public and private institutions of higher education, nonprofits (including those with and without 501(c)(3) status, other than institutions of higher education), small businesses, for-profit organizations (other than small businesses), independent school districts, and a range of local, county, state, and tribal government entities. The announcement also lists additional eligible categories such as faith-based and community-based organizations, Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, U.S. territory or possession agencies, regional organizations, eligible federal agencies, and non-U.S. entities (foreign organizations). There is no cost sharing or matching requirement. The FOA was posted March 28, 2008, created December 5, 2008, and had a closing date of May 7, 2011 (archived June 7, 2011), indicating it is no longer active, but it provides a clear example of NIH priorities in symptom science and symptom cluster research during that period.

In practical terms, a strong application under this FOA would typically define a patient population (for example, people receiving a specific cancer therapy or living with a particular immune disorder), justify a set of symptoms that are hypothesized to be linked (such as fatigue, sleep disturbance, pain, depression, cognitive changes, or treatment-related symptoms), and then propose a design that can actually test interaction effects rather than simple correlations. Competitive projects would also be expected to specify plausible mechanisms, select measures that capture both symptom experience and relevant biologic or behavioral mediators, and, if proposing an intervention, explain why targeting the interaction pathway should produce better outcomes than treating symptoms independently.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Genome Wide Association Analysis of Existing Data Sets for Arthritis and Musculoskeletal and Skin Diseases (R01)

Previous opportunity: Symptom Interactions in Cancer and Immune Disorders (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 08 122

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 08 122) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 122", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.